结直肠癌
医学
微卫星不稳定性
免疫疗法
癌症
靶向治疗
肿瘤科
癌症研究
化疗
内科学
生物信息学
生物
微卫星
基因
生物化学
等位基因
作者
Patrícia Guerrero,Víctor Albarrán,María San Román,Carlos González-Merino,Coral García de Quevedo,Jaime Moreno,Juan Carlos Calvo,Guillermo González,Inmaculada Orejana,Jesús Chamorro,Íñigo Martínez-Delfrade,B.I. Morón,B. Frutos,Reyes Ferreiro
出处
期刊:Cancers
[Multidisciplinary Digital Publishing Institute]
日期:2023-10-31
卷期号:15 (21): 5243-5243
被引量:27
标识
DOI:10.3390/cancers15215243
摘要
Metastatic colorectal cancer (mCRC) with mutated BRAF exhibits distinct biological and molecular features that set it apart from other subtypes of CRC. Current standard treatment for these tumors involves a combination of chemotherapy (CT) and VEGF inhibitors. Recently, targeted therapy against BRAF and immunotherapy (IT) for cases with microsatellite instability (MSI) have been integrated into clinical practice. While targeted therapy has shown promising results, resistance to treatment eventually develops in a significant portion of responsive patients. This article aims to review the available literature on mechanisms of resistance to BRAF inhibitors (BRAFis) and potential therapeutic strategies to overcome them.
科研通智能强力驱动
Strongly Powered by AbleSci AI